[ 메디채널 김갑성 기자 ] 쑤저우, 중국 2025년 7월 15일 -- 인공지능(AI) 기반 신약 개발의 선구자인 디바믹스(Divamics)가 첨단 AI 및 분자동역학(molecular dynamics, MD) 플랫폼을 통해 대사 질환 치료제 발전에 핵심적인 역할을 하고 있다고 밝혔다. 이 강력한 플랫폼은 최근 비만 치료를 위한 새로운 이중 작용체(AMY3R/CTR 수용체 작용제)인 BGM1812 설계를 지원했고, 이는 '의약화학 저널(Journal of Medicinal Chemistry)' 2025년 7월호에 발표됐다. 이러한 성과는 파트너사의 신약 개발 파이프라인을 지속적으로 가속화할 수 있도록 지원해 온 디바믹스의 역량을 입증하는 사례다. 협업적 신약 개발에서 AI 기반 효율성 및 정밀도 디바믹스의 플랫폼은 펩타이드-수용체 간 상호작용을 정밀하게 최적화함으로써, BGM1812의 수용체 결합력을 크게 향상시키는 데 핵심적인 역할을 했다. 전임상 연구에서는 BGM1812가 시험관 내(in vitro) 효능이 50% 향상되었고, 생체 내(in vivo) 실험에서도 유의미한 체중 감소와 대사 지표 개선이라는 뛰어난 치료 효
[ 메디채널 김갑성 기자 ] How Avio Health Is Rewiring Medicine for the Age of AI PALO ALTO, Calif. , July 15, 2025 -- Today, Avio Health announced the launch of its proprietary clinical AI platform, which is designed to unify health data and support the shift toward preventative, personalized care. By integrating lab results, wearable data, genomics, imaging, and patient histories, the platform provides both clinicians and—soon—consumers with a comprehensive, actionable view of health status. In current healthcare systems, medical and wellness data are often stored in isolated silos. La
NEW YORK, July 15, 2025 -- For those who need reliable oxygen support without compromising mobility, VARON proudly introduces the VP-8G portable oxygen concentrator — its lightest and most advanced portable oxygen concentrator to date. Engineered for active users, the VP-8G combines powerful performance with effortless portability, offering eight adjustable pulse flow settings and delivering consistent oxygen purity of 93% ±3%, all in a sleek, travel-ready design. "This isn't just a smaller oxygen machine — it's the freedom to breathe," said VARON
BASEL, Switzerland and SEOUL, South Korea, July 15, 2025 -- OSR Holdings, Inc. (NASDAQ: OSRH), a global healthcare company dedicated to advancing healthcare outcomes and improving the quality of life for people and their families, today announced the appointment of Dr Andreas Niethammer, M.D., Ph.D., as Chief Medical Officer of Vaximm AG, an OSR Company developing a platform of orally administered target-specific T-cell activators, including VXM01, a clinical stage anti-VEGFR-2. . Dr. Niethammer is an internationally recognized oncology expert with over two decades of experienc
Scientists Unveil 4DMedical Imaging Breakthrough that Spots Early Lung Disease Missed by Standard Tests LOS ANGELES, July 15, 2025 -- Researchers at Vanderbilt University, Johns Hopkins University, University of Miami, and The Alfred Hospital studied the lungs of subjects including Veterans using technology developed by 4DMedical called X-ray Velocimetry Lung Ventilation Analysis Software (XV LVAS®). Findings of the major, multi-center study were described in the article, "X-ray velocimetry provides temporally and spatially-resolved biomarkers of lung ventilation in sm
SEOUL, South Korea, July 15, 2025 -- AIRS Medical, pioneers in AI-powered solutions for diagnostic imaging, today announced a major update1 to SwiftMR, the software that reduces MRI scan times by up to 50%2 while enhancing image quality. The latest release introduces new capabilities designed to give providers more flexibility and independence in their MRI operations. Putting imaging teams in command AIRS Medical is giving users more control than ever before. With this update, clinical teams can now be trained to personalize scan settings directly within SwiftMR. This
서울, 대한민국, 2025년 7월 15일 -- AI 기반 진단 영상 솔루션 선도 기업인 에어스메디컬(AIRS Medical)이 오늘 SwiftMR의 대대적인 업데이트1를 발표했다. SwiftMR은 MRI 촬영 시간을 최대 50% 2 단축하면서 영상 품질을 향상시키는 소프트웨어다. 이번 최신 버전은 의료진에게 더 큰 유연성과 자율성을 제공할 수 있도록 설계된 새로운 기능들을 포함하고 있다. 영상팀의 운영 자율성 대폭 향상 에어스메디컬은 이번 업데이트를 통해 사용자에게 그 어느 때보다 강력한 통제 권한을 부여한다. 임상팀은 이제 SwiftMR 내에서 직접 스캔 설정을 개인화하는 방법을 교육받아 활용할 수 있다. 이를 통해 의료 시스템과 엔터프라이즈 네트워크 전반에서 영상 표준화가 가능해진다. 이제 사용자는 임상적 요구에 따라 영상 설정을 조정하고, 신체 부위별로 프로토콜을 정밀하게 조정하며, 즉시 독립적으로 변경 사항을 적용할 수 있는 자율성을 갖추게 됐다. 이번 업데이트에는 다음과 같은 주요 개선 사항이 적용됐다. 보안 업그레이드 – 더 강력한 암호 정책, 다단계 인증, 더 스
PLANO, Texas, July 15, 2025 -- Argon Medical, a leading provider of medical device solutions for Interventional Radiology, Vascular Surgery, Interventional Cardiology, and Oncology procedures, announces the grand opening of its new Distribution & Education Center (ADEC), strategically located in Derby, United Kingdom. This state-of-the-art facility represents a major step forward in the company's global operations, serving as a dedicated hub for over 80 countries across Europe, Africa, the Middle East (EMEA), and Asia-Pacific (APAC) regions. Spanning more than 20,0
LIAOCHENG, China, July 15, 2025 -- Amidst global challenges in chronic disease prevention and health management, Traditional Chinese Medicine (TCM)'s core principles of "preventive treatment of disease" (zhi wei bing, 治未病) and "harmony between humanity and nature" (tian ren he yi, 天人合一) are gaining international attention. The TCM cultural program The Young TCM Masters, co-produced by Dong-E-E-Jiao Co., Ltd, Shandong Radio and TV station, and Tencent Video, has achieved 5 billion online impressions through its innovative youth-oriented narrative. The program dismant
[ 메디채널 김갑성 기자 ] Joint effort to explore innovative cancer treatment solutions and broaden options for customers HONG KONG, July 15, 2025 -- AXA China Region Insurance Company (Bermuda) Limited, together with AXA International Reinsurance (Shanghai) Company Limited ("AXA"), is pleased to announce the signing of a strategic Memorandum of Understanding (MoU) with China Biotech Services Holdings Limited ("China Biotech Services"). The collaboration aims to explore innovative cancer treatment technologies, including Boron Neutron Capture Therapy ("BNCT") and